At the Pharmacy Benefit Management Institute's 2026 Annual National Conference in Orlando, Florida, Amy Wadstrom, RPh, ...

Federal and state laws now require PBMs to report drug pricing, rebates, and prior authorization data, creating compliance ...

FDA expands accelerated approval of oral sevabertinib for first-line HER2-mutant lung cancer, offering targeted treatment with strong response rates versus standard chemotherapy.

Preschoolers who are constantly "on the go" or interrupt others are up to six times more likely to receive an ADHD diagnosis, ...

Mahajan has been named chief financial officer (CFO) of Prime Therapeutics, effective immediately, the pharmacy benefit manager (PBM) announced in a news release today. He succeeds Ken Bodmer, who is ...

PBM, employer and pharmacy leaders at the Pharmacy Benefit Management Institute annual meeting said actionable data and real-time technology, not just transparency, are needed to control rising costs.

Patients with challenging cases of atrial fibrillation (AFib) have a new treatment option now that the FDA has approved ...

Kaiser Permanente’s contracting emphasizes acquisition cost and total value, enabling savings to flow to the health system ...

Researchers found that women with endometriosis had an overall 46% higher risk of developing Type 2 diabetes, with risk varying across different forms of endometriosis. The risk was highest among ...

A new review says outcome tools like IHS4-55 and HiSQOL should replace or supplement HiSCR to better measure hidradenitis suppurativa treatment success.

Vertex’s Journavx (suzetrigine) allowed 76.1% of patients to recover from laparoscopic or arthroscopic surgery without a ...

University of Maryland researchers used machine learning models trained on claims data of adults with diabetes to predict ...